Skip to main content
Livermore
Livermore
ZHEN

Advisor Group Holdings, Inc.

SEC CIK
0001677044
Latest filing
Aug 14, 2026

ATRA holding history

Atara Biotherapeutics, Inc. in every 13F filed by Advisor Group Holdings, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ATRA overviewAll 13F holders of ATRAFull Q2 2026 holdings

Shares (Q2 2026)
10
Value
$114
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ATRA by Advisor Group Holdings, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610$114<0.1%00.0%UnchangedHolders
Q1 202610$47<0.1%00.0%UnchangedHolders
Q4 202510$180<0.1%00.0%UnchangedHolders
Q3 202510$138<0.1%00.0%UnchangedHolders
Q2 202510$77<0.1%00.0%UnchangedHolders
Q1 202510$59<0.1%−600−98.4%ReducedHolders
Q4 2024610$8.12K<0.1%−34−5.3%ReducedHolders
Q3 2024644$5.24K<0.1%+644NewHolders
Q2 20240$00.0%−669−100.0%Sold outConverted for a 1-for-25 splitHolders
Q1 202416,734$11.6K<0.1%+14,500+649.1%AddedHolders
Q4 20232,234$1.15K<0.1%−2,190−49.5%ReducedHolders
Q3 20234,424$6.55K<0.1%+109+2.5%AddedHolders
Q2 20234,315$6.95K<0.1%−274−6.0%ReducedHolders
Q1 20234,589$13.3K<0.1%−66−1.4%ReducedHolders
Q4 20224,655$15.8K<0.1%+3,804+447.0%AddedHolders
Q3 2022851$3.00K<0.1%−17−2.0%ReducedHolders
Q2 2022868$7.00K<0.1%+113+15.0%AddedHolders
Q1 2022755$7.00K<0.1%−123−14.0%ReducedHolders
Q4 2021878$14.0K<0.1%+236+36.8%AddedHolders
Q3 2021642$11.0K<0.1%−649−50.3%ReducedHolders
Q2 20211,291$21.0K<0.1%−74−5.4%ReducedHolders
Q1 20211,365$19.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.